skip to primary navigation
skip to content
View menu
Search
Study at Cambridge
About the University
Research at Cambridge
Quick Links
For staff
For alumni
For business
Colleges & departments
Libraries & facilities
Museums & collections
Email & phone search
Site Search
Site Search
Home
Study at Cambridge
Undergraduate
Courses
Applying
Events and open days
Fees and finance
Student blogs and videos
Graduate
Why Cambridge
Qualifications directory
How to apply
Fees and funding
Frequently asked questions
International students
Continuing education
Executive and professional education
Courses in education
About the University
How the University and Colleges work
History
Visiting the University
Term dates and calendars
Map
For media
Video and audio
Find an expert
Publications
International Cambridge
News
Events
Public engagement
Jobs
Giving to Cambridge
Research at Cambridge
For staff
For current students
For alumni
For business
Colleges & departments
Libraries & facilities
Museums & collections
Email & phone search
Home
/
Clinical Neurosciences
/
Cambridge Clinical Multiple Sclerosis Research
/
General information
Home
Cambridge Clinical Multiple Sclerosis Research
Home
Our Research
Trials
CCMR2: a trial of metformin and clemastine as remyelinating drugs in MS
CCMR1: a trial of a bexarotene in multiple sclerosis
SINAPPS2: a clinical trial in psychosis
Big Data
Remyelination
Children with MS
Cambridge Centre for Myelin Repair
Alemtuzumab
History of Alemtuzumab
For prescribers
Alemtuzumab Trial Results
Current Grants
Antibodies in neurological disease
Our People
Coles Group
Cunniffe Group
Brown Group
Patient advisory group
Past Members
Publications
Get involved
As a PhD student or researcher
As a patient collaborator
As a trial participant
For work experience
Multiple Sclerosis
Support our research
News
Contact Us
General information
